New York covid-19 prevention infection New York

Pfizer studying oral drug to prevent COVID-19 in those exposed

Reading now: 221

NEW YORK - Pfizer has begun mid-to-late stage trials of an oral COVID-19 drug designed to prevent infection in those who have been exposed to the coronavirus.The drugmaker said Monday it has launched Phase 2/3 of a global clinical trial that aims to enroll up to 2,660 healthy adults who live in the same household as an individual with a confirmed, symptomatic COVID-19 infection. "If successful, we believe this therapy could help stop the virus early – before it has had a chance to replicate extensively – potentially preventing symptomatic disease in those who have been exposed and inhibiting the onset of infection in others," Dr.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News